The effect of ranibizumab and aflibercept treatment on the prevalence of outer retinal tubulation and its influence on retreatment in neovascular age-related macular degeneration

被引：0
|
作者：
Attila Kovacs
Timea Kiss
Ferenc Rarosi
Gabor M. Somfai
Andrea Facsko
Rozsa Degi
机构：
[1] University of Szeged,Department of Ophthalmology, Faculty of Medicine
[2] University of Szeged,Department of Medical Physics and Informatics, Faculty of Medicine
[3] Augenzentrum Pallas Kliniken,Department of Ophthalmology, Faculty of Medicine
[4] Semmelweis University,undefined
来源：
BMC Ophthalmology | / 18卷
关键词：
Outer retinal tubulation; Prevalence; Anti-VEGF; Aflibercept; Retreatment; Subretinal hyperreflective material;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Review of Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration
    Stewart, Michael W.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2013, 5 : 81 - 93
  • [22] Experience With Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration
    He, Lingmin
    Silva, Ruwan A.
    Ayoub, Noel
    Moshfeghi, Darius M.
    Leng, Theodore
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (05): : 542 - 549
  • [23] Ranibizumab in neovascular age-related macular degeneration
    Eng, Kenneth T.
    Kertes, Peter J.
    CLINICAL INTERVENTIONS IN AGING, 2006, 1 (04) : 451 - 466
  • [24] Intravitreal aflibercept: its role in treatment of neovascular age-related macular degeneration
    Cundy, Olivia
    Shah, Mital
    Downes, Susan M.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2018, 13 (02) : 75 - 86
  • [25] Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration
    Lai, Timothy Y. Y.
    Chan, Wai-Man
    Liu, David T.
    Lam, Dennis S.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 245 (12) : 1877 - 1880
  • [26] Treatment of neovascular age-related macular degeneration with Ranibizumab/LucentisTM
    Michels, S
    Rosenfeld, PJ
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2005, 222 (06) : 480 - 484
  • [27] Ranibizumab: A Review of Its Use in the Treatment of Neovascular Age-Related Macular Degeneration
    James E. Frampton
    Drugs & Aging, 2013, 30 : 331 - 358
  • [28] Ranibizumab for the treatment of neovascular age-related macular degeneration: A review
    Kourlas, Helen
    Abrams, Paris
    CLINICAL THERAPEUTICS, 2007, 29 (09) : 1850 - 1861
  • [29] Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
    Martin, Daniel F.
    Maguire, Maureen G.
    Fine, Stuart L.
    Ying, Gui-shuang
    Jaffe, Glenn J.
    Grunwald, Juan E.
    Toth, Cynthia
    Redford, Maryann
    Ferris, Frederick L., III
    OPHTHALMOLOGY, 2012, 119 (07) : 1388 - 1398
  • [30] Ranibizumab: A Review of Its Use in the Treatment of Neovascular Age-Related Macular Degeneration
    Frampton, James E.
    DRUGS & AGING, 2013, 30 (05) : 331 - 358
12345